Printer Friendly

Schering-Plough to close plant.

Schering-Plough Corp. is cutting 1,100 jobs, closing one plant in Puerto Rico and streamlining operations at other plants there and in New Jersey, reports Bloomberg (June 2, 2006). The plant at Manati, Puerto Rico, will close by the end of 2006, the company said. Schering-Plough, developer of the Claritin and Clarinex allergy drugs, has been working on a turnaround program since Claritin lost patent protection in 2002, leading to three years of losses. About 550 full-time positions will be eliminated at the Manati plant, which makes Nasonex, an allergy spray, and Afrin, an over-the-counter decongestant. A further 50 jobs will be cut at a plant in Las Piedras, Puerto Rico, which will continue to operate, employing 475 people. That plant makes Zetia, for cholesterol control; Clarinex, an allergy medication; and Rebetol, for hepatitis B.
COPYRIGHT 2006 Caribbean Update, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:PUERTO RICO
Publication:Caribbean Update
Geographic Code:1U0PR
Date:Jul 1, 2006
Words:135
Previous Article:US$675 million bond issue postponed.
Next Article:New bldg. complex in Hato Rey.
Topics:


Related Articles
SCHERING-PLOUGH PROBE CLOSED.
Manufacturing update.
Pfizer to close Arecibo Plant.
Pharmaceutical plant to close.
Novacea and Schering-Plough enter into worldwide development and commercialization agreement for Asentar.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters